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Abstract
Panton-Valentine Leucocidin (PVL), one of the b-barrel pore-forming staphylococcal leucotoxins, is known to be associated
to furuncles and some severe community pneumonia. However, it is still uncertain how many other virulence factors are
also associated to furuncles and what the risk factors of furuncles are in immuno-compromised status of patients, especially
the HIV (+) patients. In this paper, we use antigen immunoprecipitation and multiplex PCR approach to determine the
presence of 19 toxins, 8 adhesion factors and the PFGE profiles associated to furuncles in three independent patient study
groups of S. aureus (SA) isolates collected from the Cayenne General Hospital (French Guiana). The patient groups were
made of: 16 isolates from HIV (2) patients, 9 from HIV (+) patients suffering from furuncles, and 30 control isolates from
patients with diverse secondary infected dermatitis. Our data reveals that the majority (96%) of SA strains isolated from HIV
patient-derived furuncles significantly produced PVL (p,1027), whereas only 10% of SA strains produced this toxin in
secondary infected dermatosis. A high prevalence of LukE-LukD-producing isolates (56 to 78%) was recorded in patient
groups. Genes encoding clumping factor B, collagen- and laminin-binding proteins (clfB, cna, lbp, respectively) were
markedly frequent (30 to 55%), without being associated to a specific group. Pulse field gel electrophoresis evidenced 24
overall pulsotypes, whereas the 25 PVL-producing isolates were distributed into 15 non clonal fingerprints. These
pulsotypes were not specific PVL-producing isolates. PVL appears to be the major virulence factor associated to furuncles in
Europe and in South America regardless of the immune status of the HIV patients.
Citation: Baba-Moussa L, Sina H, Scheftel J-M, Moreau B, Sainte-Marie D, et al. (2011) Staphylococcal Panton-Valentine Leucocidin as a Major Virulence Factor
Associated to Furuncles. PLoS ONE 6(10): e25716. doi:10.1371/journal.pone.0025716
Editor: Paulo Lee Ho, Instituto Butantan, Brazil
Received July 19, 2011; Accepted September 8, 2011; Published October 12, 2011
Copyright:  2011 Baba-Moussa et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: These authors have no support or funding to report.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: laminesaid@yahoo.fr
Introduction
Staphylococcus aureus (SA) are known to produce a large series of
toxins [1,2] and adhesion factors [3,4] considered as virulence-
associated factors. Among the virulence factors associated to
clinical syndromes, only few were initially considered in most of
original studies [5,6,7]. For example, the Panton Valentine
leucocidin (PVL)-producing SA strains were successively associated
to furuncles and carbuncles [5,6,8,9] and/or to community
pneumonia with lung abscesses [10,11,12].
PVL was initially identified because of the acute cytotoxicity of
some culture supernatants of SA isolates from furuncles and
staphylococcal necrotizing follicular infections of the skin [13,14].
PVL is a skin-necrotizing toxin when intradermally injected into
rabbits [15]. This bipartite toxin is an active pore-forming toxin
against human polymorphonuclear cells, monocytes and macro-
phages [16]. However, the two protein components of PVL, LukS-
PV and LukF-PV, may recombine with other related leucotoxins
components, to generate new leucotoxins with specific cell spectra
[17]. The newly formed toxins such as PVL and gamma-
hemolysins (HlgA-HlgB or HlgC-HlgB sometimes called LukS-
LukF) may be expressed at different levels [18] with highly variable
binding constants to cells [19]. Sequence and three-dimensional
structures of LukS-PV and LukF-PV have been determined
[20,21], and the interaction of LukS-PV with a membrane
receptor was strongly suggested [19].
The origin and recurrence of furuncles as primary infections, and
their severity in some patients remain unclear. This has been related
to the nasal carriage of the bacterium [14], but this may suggest a role
of innate immunity. Immunosuppressed HIV (+) patients develops
frequently SA skin infections such as folliculitis and sometimes
furuncle [22]. There is still no evidence of virulence factors in SA
isolated from staphylococcal infections in HIV (+) patients. In
addition, the possibility that immunodeficiency status of the patient
may modify susceptibility to SA virulence has never been proved.
In this work we analyzed the toxin profile and adhesion factors
of SA isolated from HIV positive and negative patients at the
Cayenne General Hospital, the principal hospital in French
Guiana, in South America, where HIV prevalence in adults was
1,6%. SA was isolated from independent furuncle and furuncle free
patients. A comparative study of different SA toxins and adhesion
factors was performed in order to establish the eventual association
of virulence factors other than PVL, especially in HIV positive and
negative patients with respect to secondary skin infections.
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Materials and Methods
Ethics Statement
Samples collected from patients at French Guiana hospital
center were anonymously sent to the University of Abomey-
Calavi, Benin (West Africa) for microbial screening, while PFGE
analysis were performed at Strasbourg University, Strasbourg,
France. The authors had no access to the patient medical data,
with the exception of anonymous clinical sample data such as ages,
HIV status, skin infections. This work is mainly focused on the
bacterium SA virulence factors and not on the patients, and was
therefore exempted from ethical approval.
Collected samples and clinical data
We collected SA isolates from 55 patients in Cayenne General
Hospital (French Guiana). These patients were classified in three
groups according to infectious origin: 30 patients with staphylo-
coccal secondary skin infections (eczema: 13, wound: 7, prurigo: 6
and diverse dermatosis: 4), 16 HIV (2) patients with furuncles and
9 HIV (+) patients with furuncles. The HIV (+) status was
discovered for 2 patients with furuncles by ELISA and Western
blot, consecutively confirmed by dermatology consultation test
(where HIV test was systematically proposed when a furuncle was
diagnosed) and 7 patients were previously diagnosed as HIV (+)
and they were regularly followed at hospital. The median of the
CD4+ lymphocytes in HIV (+) patients was 225 U/mm3 (42–896).
Four patients had CD4+ lymphocytes,200/mm3 and one,100/
mm3. Among the HIV (+) patients, only one suffered of cerebellar
toxoplasmosis.
The other patients were consecutively seen at dermatological
consultation. In this study, only patients presenting lesions like
furuncles or secondary skin infections of a pre-existing non
infectious dermatosis due to SA were included. The demographic
and clinical characteristics of patients were recorded before the
bacteriological sampling on the lesion. The mean age of all 55
patients was 25.4 year old (1–69). It was 18.3 (1–55), 28.8 (2–56),
44.6 (20–69), respectively, for the patients with secondary
infections, HIV (2) patients and HIV (+) patients. The sex ratio
was 1.3.
Susceptibility to antibiotics
Antibiograms for the isolates were obtained by the disk diffusion
method (Bio-Rad-Diagnostic Pasteur, Marnes la Coquette,
France). Isolates were inoculated and antibiotics were tested
according to the 2010 Antiobiogram Committee of the French
Society of Microbiology and the NCCLS recommendations [23]:
Oxacillin (Oxa), Penicillin G (PeG), Vancomycin (Va), Teicopla-
nin (Tec), Kanamycin (Kan), Tobramycin (Tob), Chloramphen-
icol (Chl), Rifampicin (Rif), Fusidic acid (Fus), Gentamicin (Gm),
Trimetroprim Sulfamethozolin (Sxt), Ofloxacin (OXF), Pristina-
mycin (Pt), Linezolide (Lzd) and Erythromicin (Ery) have been
tested. Evaluation of methicillin resistance was performed by
plating the strains on buffered Mueller-Hinton agar with 2% (wt/
vol) NaCl at 37uC for 24 h.
Phenotypic detection of toxins
Enterotoxins A, B, C, and D and TSST-1. SA cultures were
carried out overnight in 3 mL of Brain-Heart (Difco) medium
under shaking, and toxins were detected using the semi-
quantitative reversed passive latex agglutination detection kits
SET-RPLATM and TST-RPLATM (Oxoid, Basingstoke, England).
These tests were reported to be sensitive and specific, although
large amounts of enterotoxin E may be detected as low levels of
enterotoxin A [24].
Bicomponent leucotoxins and epidermolysins. The
different leucotoxins (PVL, LukE-LukD, LukM-LukF-PV, and
the gamma-hemolysin proteins HlgA, HlgB, and HlgC),
epidermolysins A and B were evidenced from culture
supernatants after 18 h of growth in YCP medium [19] by
radial gel immunodiffusion in 0.6% (wt/vol) agarose in 10 mM
Hepes, 150 mM NaCl, pH 7.5 with component-specific rabbit
polyclonal and affinity-purified antibodies [14]. For a better
determination, gels were dried, stained in Coomassie blue, and
destained in 10% (vol/vol) acetic acid.
Genotype detection of toxins and adhesion factors
Presence of genes encoding entorotoxins SEE, SEG, SEH,
SEK, SEL, SET, epidermolysin D (etd), Edin factors (edinA, edinB,
edinC) and of genes encoding eight adhesion factors: Collagen
Binding Protein (Cna), Fibronectin Binding Proteins A and B (fnbA
and fnbB), Bone Sialoprotein Binding Protein (bbp), Clumping
Factor B (clfb), Fibrinogen Binding Protein (fib), Elastin Binding
Protein (ebp) and Laminin Binding Protein (lbp) was detected by
Multiplex PCR (Table 1). Additionally, genes encoding PVL were
also detected with oligonucleotides previously used for expression
studies [18]. Total DNA was purified using QIAampH DNA Mini
Kit (Qiagen, GmbH, Germany) with a Gene AmpH PCR System
9700 (Perkin-Elmer, Norwalk, USA) and amplified in a total
volume of 50 ml containing 25 pmoles of each primer, 50 ng of
total DNA, 1.5 mM MgCl2, 200 mM of dNTP mixture, 16PCR
reaction Buffer and 5 units of FastTaqTM DNA polymerase
(Roche Applied Science, GmbH, Germany). The thermal cycling
conditions included an initial denaturation step (2 min at 92uC)
followed by 35 cycles of amplification comprising three steps:
2 min denaturation for 92uC, 1 min annealing at 50uC, 2 min
extension at 72uC. The reaction was terminated with 3 min
extension at 72uC. PCR products were analysed by electrophoresis
through 1.4% (wt/vol) agarose gel (Euromedex, Mundolsheim,
France).
Pulse Field Gel Electrophoresis (PFGE)
SA strains at mid-exponential growth in 25 ml of TY (1.6% [w/
v] BioTrypcase, 1% [w/v] yeast extract, 0.5% [w/v] NaCl,) were
embedded in agarose plugs as described previously [25]. After lysis
of plugs by proteinase K (Sigma) for 18 h at 56uC, plugs were
washed and stored at 4uC in 10 mM Tris-HCl, 1 mM EDTA
(pH 8.0). Plugs (agarose plugs, 2.5 by 5.0 by 1 mm) were
equilibrated in 300 mL of restriction enzyme buffer for 30 min
at 4uC. DNA macro-restriction was then accomplished in 60 mL
with 10 U of Sma I (New England Biolabs, Beverly, Mass.) for 4 h
at room temperature. Electrophoresis was performed at 12uC with
a Beckman GenelineTM Transverse Alternating Field Electropho-
resis (TAFE) system at 150 mA in 0.56 TAFE system buffer
(TAFE buffer is 0.2 M Tris, 10 mM free acid EDTA, and 87 mM
CH3COOH [pH 8.2]) in a 1% (w/v) agarose gel. Electrophoresis
of SmaI-fragmented DNA was carried out with 2-s pulses for 1 h,
followed by 14-s pulses for 1 h, 12-s pulses for 1.5 h, 10-s pulses for
2.5 h, 8-s pulses for 6 h, and 6-s pulses for 6 h. Bacteriophage
lambda PFG Marker (New England Biolabs) was used as a
molecular marker. The gels were stained with ethidium bromide
and photographed under UV trans-illumination. Pulsotypes were
compared and classified in a dendrogram using the Dice
coefficient and the unweighted pair group method with arithmetic
mean clustering provided by Molecular AnalystTM (version 1.5)
and FingerprintingTM (version 1.12) softwares (Bio-Rad, Ivry sur
Seine, France). Isolates that differed by no more than three
fragments were considered to be subtypes of a given clonal type.
PVL Strongly Associated to Furuncle
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Statistical analysis
For comparison tests of positive isolates of each patient group,
we used the Student T test, and the Fischer’s test for lower number
series (SPSS Ltd software, version 10.1). P,0.05 was considered
statistically significant.
Results
Susceptibility to antibiotics
In this study, no isolate was resistant to oxacillin or gentamicin.
However, production of b-lactamase was observed for all isolates
of the three groups with the exception of one isolate of the control
group. In addition, the isolates were generally sensitive to all tested
antimicrobials with the exception of few SA that were resistant to
fusidic acid, i.e. 9 of the 10 fusidic acid resistant isolates were from
the control group, or to erythromycin, i.e. 9 of the 11 erythromycin
resistant isolates were also issued from the control group.
Comparative analysis of toxins production
The presence of the staphylococcal toxins in the different groups
is detailed in the Table 2. A great majority (96%) of the SA strains
isolated from furuncles regardless of status of the HIV patient
produced PVL, while only 10% of the isolates originated from
secondary infected dermatosis produced this toxin (Table 2). This
difference between furuncles and non-furuncles populations was
significant (p,1027). All the strains isolated from furuncles of HIV
(2) patients produced PVL, while it is produced by 89% of the
isolates obtained from furuncles of HIV (+) patients. Only PVL-
producing isolates were also detected for the presence of
corresponding genes, conversely to the LukE/LukD leucotoxin.
In fact, the lukE/lukD locus was detected in most SA isolates (92%),
but the effective production of the corresponding LukE/LukD
leucotoxin was observed only for 64% of isolates obtained from
furuncles and for 76% of those from secondary infected dermatosis
(Table 2). Therefore, no noticeable difference between groups
could be drawn in this study. This result illustrates heterogeneity
between SA isolates from our sample collection in regards to the
occurrence of LukE/LukD production [24,26,27]. Epidermolysin
A (ETA) is produced by 16% of isolates from secondary infected
dermatosis. The presence of enterotoxins A and G yielded 23%
and 16% in the group of secondary infections respectively, while
only 4% and 16% in the cumulated groups of furuncles,
respectively. Finally, no more than 40% (12/30) of the secondary
dermatitis- and no more than 36% (9/25) of the furuncle-
originated isolates produced one at least of the most encountered
superantigens.
Comparative analysis of the presence of adhesion factors
The distribution of 8 genes encoding adhesion factors were
examined (Table 3). Gene encoding FnBA was carried out in all
tested isolates. In the groups of the strains isolated from furuncles
and the secondary infected dermatitis, no isolate carries genes
encoding Fib, Cna, FnBb, Bbp. The presence of ClfB seemed to be
linked to the presence of Lbp, since all the strains carrying clfB also
carried lbp. Ebp is produced by 48% of the isolates from furuncles,
while it is produced by 30% in the case of non-infected dermatitis.
Concerning the two HIV (+) and HIV (2) patient groups, the
genes encoding the adhesion factors ClfB, Lbp, and EBP are
present respectively at 6/16, 6/16 and 7/16 for HIV (2) group
and 4/9, 4/9 and 5/9 for HIV (+) group.
Pulsed Field Gel Electrophoresis (PFGE)
Pulsed field gel electrophoresis defined 24 SmaI-pulsotypes differing
by more than two DNA fragments for the 55 different isolates, which
Table 1. Primers used for PCR detection of genes encoding
virulence factors.
Oligonucleotides sequences
size pb/
PCR set accession n6
edinA 1: 59-
TCATAGAAGTATCTAATACTTCTTTAGCA-39
604/2 M63917
edinA 2 : 59-
TCCAACACGGTATTCTGTGCCTCTAGGTA-39
edinb 1: 59-ACAGACTTAGTTGAAGCTACT-
AAATG-39
522/5 AB057421
edinb 2: 59-TGTCCCTGTAGGCAAAAGAAC-
TTCTTG-39
edinC 1: 59-AGGTCTTCCAGCTAATGCAGC-
TCCTT-39
543/6 NC 003265
edinC 2: 59-ACAGTTCAAAAGACAAAGAA-
GCTATT-39
etd 1: 59-AATACATATGAAGAATCTGAAATTTTA39 800/4 AB057421
etd 2: 59-AAGTTATTCCATAATGATTAGAATGA-39
lukE-lukD 1: 59-
AATACTAATATTGAAAATATTGGTGATGG-39
1882/8 Y13225
lukE-lukD 2: 59-
CTTAAATTTCGGGTTTAACTCCTCTATTTC-39
see 1: 59-CTTACCGCCAAAGCTGTCG-39 159/3 M21319
see 2: 59-GTCCACTTGTAAATGGTAGCGAGAA-39
seg 1: 59-AATTATGTGAATGCTCAACCCGAT-39 408/3 AF064773
seg 2: 59-CTTTAGTGAGCCAGTGTCTTGCTTTG-39
seh 1: 59-CATCTACCCAAACATTAGCACC-39 222/5 U11702
seh 2: 5-TAGAAATCAAGGTGATAGTGGCAA-39
sek 1: 59-TGATACTCCTATAGCTAATCAACTACA-39 300/3 U93688
sek 2: 5-ACATCAATCTCTTGAGCGGTAACA-39
sel 1: 59-ACCAGAATCACACCGCTTAGAATAC-39 422/2 AF217235
sel 2: 59-TGGAATACTACACTCCCCTTATCAAAAG-39
set1-1: 59-GAAGGTCTACAAGGCCAAAATGTCT-39 363/6 BX571856
set1-2: 59-TCAACACATCGCCCATGCGCTCGA-39
bbp 1: 59-CGGCTAGTGATAATAAAGAAGTAGTG-39 550/1 BA000018
bbp 2: 59-CTTGTTGGAGCTGTAGCAACTGGTTT-39
clfB 1: 59-ATTAGTGCAAACACAAACAGTGCG-39 305/4 AJ224764
clfB 2: 59-AGTTCCTTGCGCATTGGAAATCGT-39
cna 1: 59-CGGGAGATATGCTACCAGAAGATA-39 278/1 BX571857
cna 2: 59-ATAGCCTTGTGGAATTGTTACATCA-39
ebp 1: 59-AGACCAATCAGAATTAGAACATCA-39 378/4 U48826
ebp2: 59-TCAGAAACTGTTGAATGCTCAGTGT-39
fib 1: 59-AGCGGCAATAGGTATTACTACAACT39 220/2 X72013
fib 2: 59-CGAATGTACCATCGTTAAATTCAT-39
fnbA 1: 59-TTAACTTGGGATAATGGTTTAGTTT-39 273/7 AJ629521
fnbA 2: 59-GCTGATGAATCCGTTTCTTCTATTG-39
fnbB 1: 59-TGGAAGAAACTAAAGCGACAGGTAC-39 317/1 AJ629502
fnbB 2: 59-TTCTTTAAACGTATATCTAACTTTTC-39
lbp 1: 59-TGGTGTATATGACTACAGTAAGTT-39 410/5 AF065394
lbp 2: 59-CGTTTGTAGCAACAGCAATATCAGC-39
Other virulence factors have been detected by multiplex PCR onto purified total
DNA (Qiagen). Presence of genes encoding enterotoxins E, G, H, K, L, T,
epidermolysin D (Etd), genes encoding Edin A and EDIN B and the genes
encoding seven adhsesion factors (Cna, FnbA, FnbB Bbp, Clfb, Fib, Ebp and Lbp)
was checked in 8 set in function of base size.
doi:10.1371/journal.pone.0025716.t001
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therefore, exclude clonal relationships between isolates (Figure 1).
Among the different pulsotypes, which account for a diverse
collection of SA genotypes in French Guiana, some were identified
in both furuncles and secondary pyodermites isolates. Therefore,
PVL-producing isolates cannot be referred to as a specific category of
pulsotype. According to the isolates, 9 to 14 defined DNA fragments
of lengths comprised between 20 kb and 600 kb after SmaI restriction.
Six of these pulsotypes were displayed by isolates belonging to
different groups including secondary dermatitis. The most represent-
ed pulsotypes nu 1, 8, 13 are composed of 7, 6, and 6 isolates
respectively. The diversity of the pulsotypes accounts for an endemic
polymorphic SA isolates in French Guiana and reinforces the PVL as
a main causative agent of furuncles.
Discussion
This study reinforces PVL as probably the major staphylococcal
virulence factor in furuncles as it is produced by almost all SA
Table 2. Production of toxins and identification of genes encoding toxins in Staphylococcus aureus.
Toxins and genes encoding toxins
Infected dermatosis
(n=30) Furuncles (n =25)
All HIV (2) (n = 16) HIV (+) (n = 9)
SEA 7 (23.3%) 1 (4.0%) 1 (6.3%) 0
SEB 3 (10.0%) 5 (20.0%) 2 (12.5%) 3 (33.3%)
SEC 4 (13.3%) 4 (16.0%) 1 (6.3%) 3 (33.3%)
SED 2 (6.7%) 1 (4.0%) 1 (6.3%) 0
TSST1 1 (3.3%) 0 0 0
ETA 5 (16.7%) 0 0 0
ETB 0 1 (4.0%) 1 (6.3%) 0
PVL 3 (10.0%) 24 (96.0%) 16 (100.0%) 8 (88.9%)
LukE/LukD 23 (76.7%) 16 (64.0%) 9 (56.3%) 7 (77.8%)
lukE-lukD 29 (96%) 22 (88%) 13 (81.5%) 9 (100%)
etd 0 0 0 0
see 0 0 0 0
seg 5 (16.7%) 7 (28.0%) 2 (12.5%) 5 (55.6%)
seh 0 0 0 0
sek 0 0 0 0
sel 0 0 0 0
set 0 0 0 0
edinB 0 0 0 0
edinC 0 0 0 0
edinA 0 0 0 0
The majority of SA strains isolated from HIV patient-derived furuncles significantly produced PVL (p,0.05), whereas only 10% of SA strains produced this toxin in
secondary infected dermatosis. A high prevalence of LukE-LukD-producing isolates (56 to 78%) was recorded in patient groups.
doi:10.1371/journal.pone.0025716.t002
Table 3. Presence of genes encoding adhesion factors of Staphylococcus aureus.
Gene encoding adhesion
factors Infected dermatosis (n=30) Furuncles (n =25)
All HIV (2) (n = 16) HIV (+) (n = 9)
bbp 0 0 0 0
cna 0 0 0 0
clfb 16 (53.3%) 10 (40%) 6 (37.5%) 4 (44.4%)
ebp 9 (30%) 12 48%) 7 (43.8%) 5 (55.6%)
fib 0 0 0 0
fnbA 30 (100%) 25 (100%) 16 (100%) 9 (100%)
fnbB 0 0 0 0
lbp 16 (53.3%) 10 (40%) 6 (37.5%) 4 (44.4%)
Genes encoding clumping factor B, collagen- and laminin-binding proteins (clfB, cna, lbp, respectively) were markedly frequent (30 to 55%), without being associated
with a specific group.
doi:10.1371/journal.pone.0025716.t003
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isolates, i.e. 96% from furuncles and (10%) (p,1027) from control
group constituted of SA isolates from non furunculous skin
infections. These results are comparable with those previously
obtained in Europe [28,29,30]. In Strasbourg (France), 85.7% of
SA strains isolated from a series of 35 furuncles produced this
toxin, while it was produced by less than 2% of strains issued from
healthy patients or patients with other staphylococci affections
[8,14]. In former studies, PVL production from routine isolates
represented 3 to 12% of isolates according to collections [14,31].
Other authors established the association with furuncles at 93%
within a series of 30 furuncles [11]. Together with other research
group, we have previously noticed that isolates obtained
simultaneously from different furuncles, or from different episodes
or in a same fratry were comparable. However, they are less
comparable if they are isolated from individuals, except when they
were obtained from outbreaks [6,32,33]. All together, the absence
of clonal relationships between these American isolates confirms
the significance of the association of PVL with furuncles.
A furuncle is characterized by necrosis of body hair follicles and
adjacent tissues. In rabbit skin, PVL induces necrosis after
intradermal injection [14,15]. The SA PVL-producing strains were
also associated to severe primitive staphylococci pneumonia with
high mortality rate, and with multiple consecutive lung abscesses to
metastastic diffusion from furuncles [10]. However, it could not be
excluded from any of these studies that another virulence factor may
be also associated with PVL. We almost excluded the role of
superantigens and other major toxins, while no specific adhesion
factor can be suspected. In fact, despite the presence of such a factor,
adhesion of SA provides a benefit to the bacterial colonisation, but a
specific adhesion remains questionable.
Our study did not found a significant difference (p=0.36)
between the PVL produced by SA strains responsible for the
furuncles regardless of the status of HIV patient considered: HIV
(+) (89%), HIV (2) (100%). Among HIV (+) patients, the chronic
nasal carriage of S. aureus is more frequent [34]. The frequency of
SA infections increased with the decreasing of immunity. Severe SA
infections are generally described among the patients with CD4+
lymphocytes less than 100 cells/mm3 [22,35]. In the case of a
chronic nasal carriage, the risk for SA infection rose to 20% per
year among patients with CD4+ ,100 cell/mm3 [35]. The
frequency of SA skin infections increased with the immunodefi-
ciency. At an advanced stage of the disease, 20% of the patients
may be concerned by a SA skin infection [22]. The furuncles or
carbuncles are within the first reported SA skin infections among
the HIV (+) patients [35,36]. Like in HIV (2) patients, in HIV (+)
patients the principal bacterial factor associated with furuncle is
PVL-producing SA infecting a follicle body hair. This data argued
for the association of PVL-production with some necrotic lesions
like furuncles and carbuncles.
For HIV (+) patients and others, furuncle is a sign of the presence
of a virulent SA-strain, which produces PVL. In the context of
advanced immunodeficiency, this infection must be particularly
cured as well as the bacterial carriage, because of the risk of
consecutive septicaemia due to this kind of strain. Recently, the
emergence of Methicillin Resistant SA (MRSA) isolates producing
Panton-Valentine Leucocidin (PVL) have been observed [37,38,39],
thus highlighting additional seriousness of potential complication.
In our study, the SA strains isolates involved in furuncles did not
harbour any specific resistance to antibiotics. The high frequency
of LukE/LukD-producing isolates observed in the groups of strains
(55 to 85%), may be due to an endemic situation, which should be
further confirmed. A markedly high frequency of some adhesion
factors Clf, Lbp and Ebp does not seem to be associated to any
particular group of isolates.
Figure 1. Pulsed field gel electrophoresis (PFGE) dependent dendogram of isolated Staphylococcus aureus. Pulsed field gel
electrophoresis (PFGE) proves no specific clonal relationship between PVL-producing isolates issued from furuncles or secondary dermatosis. The
similarity of the different pulsotypes was established by using Molecular AnalystTM software. Twenty four pulsotypes corresponded to the 55 isolates
and their distribution is given according to the groups of isolates issued from secondary infected dermatosis (1), furuncles from HIV (2)(2) or HIV
(+)(3) patients.
doi:10.1371/journal.pone.0025716.g001
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In conclusion, and like in Europe, we demonstrate here a strong
association between SA-producing PVL isolates in South America
and necrotic skin lesions such as furuncles. This association is
similar in HIV (+) and in HIV (2) patients. It remains unclear
whether such skin lesions might be considered as risk markers in
exposed patient’s populations. Absence of clonal relationships
between SA strains isolated from furuncles is an important
argument for a causal relationship between capacity of PVL
production by the SA and the development of furuncles.
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